Delivery Order SPE2DB22D2206-SPE2DB25FHC15
Award Date
5/22/25
Potential Completion Date
6/13/25
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML medication. The single-award delivery order contract has a total ceiling value of $42,558.50 and a period of performance through May 29, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a key...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,835.28 firm fixed-price delivery order is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor and there is no indication of set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product, with a ceiling value of $46,826.19. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2024. This award is not associated with any set-aside program. Amerisourcebergen, a major supplier of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML. The contract has a firm fixed price of $26,285.85 and a period of performance through June 20, 2025. The contract is not set aside and was awarded on May 29, 2025. AmerisourceBergen Drug Corp is the prime contractor for this delivery order and has a substantial $999,999,999.00 Indefinite...
This federal contract award, valued at $44,249.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty medication, with a completion date of February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,285.85, is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialized medical product. The contract is a firm fixed-price delivery order and has an ultimate completion date of April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,285.85, is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialized pharmaceutical product. The contract has a fixed-price delivery order structure and an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award and has no...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FA3M2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a medical product, with a ceiling value of $48,674.67. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 21, 2025. This contract award is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $50,634.60 firm-fixed-price contract is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a pharmaceutical product, with a completion date of January 16, 2024. AmerisourceBergen Drug Corp has previously received numerous federal contract awards from DLA to provide...
This federal contract award is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $86,555.37. This is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation,...